section name header
Index
ACE Inhibitors and Angiotensin II Receptor Blockers for Diabetics with Microalbuminuria
Administration…
Antihypertensive Agents for Preventing Diabetic Kidney Disease
Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
Association of Systolic Blood Pressure and Complications of Type 2 Diabetes
Cardiology…
Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
Comprehensive Treatment and Follow-Up of Type 2 Diabetes
Diabetes: Definition, Differential Diagnosis and Classification
Effects of Tibolone in Postmenopausal Women
Efficacy and Safety of Cholesterol Lowering by Statins
Ezetimibe for the Prevention of Cardiovascular Disease
Fibrates for Primary Prevention of Cardiovascular Disease
Glucagon-Like Peptide Analogues (GLP-1 Analogues) for Type 2 Diabetes
Glycaemic Control for Slowing the Progression of Microvascular Complications in Diabetes Mellitus
Gynaecology…
Hazards of Reducing Serum Cholesterol
Insulin Added on Metformin in Type 2 Diabetes
Intensive Versus Moderate Statin Therapy
Internal medicine…
Lipid Lowering Therapies in Renal Disease
Low-Dose Aspirin for Prevention of Vascular Events in Type 2 Diabetes
Male Hypogonadism and Hormone Replacement - Related Resources
Menopausal Hormone Therapy and Risk of Venous Thromboembolism
Menopausal Hormone Therapy and the Risk of Stroke
Menopausal Symptoms and Hormone Therapy
Menopausal Symptoms and Postmenopausal Hormone Replacement Therapy - Related Resources
Neurology…
Oral Antidiabetic Drugs and GLP-1 Analogues
Osteoporosis
Pcsk9 Inhibitors for Prevention of Cardiovascular Disease
Prevention of Type 2 Diabetes in Persons at Increased Risk for the Development of T2d
Primary Hyperaldosteronism (Pha)
Selecting Anticoagulant Therapy in Atrial Fibrillation
Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease
Sglt-2 Inhibitors in Type 2 Diabetes
Statins for Improving Renal Outcomes
Statins for the Primary Prevention of Cardiovascular Disease
Sulphonylurea for Type 2 Diabetes
Surgery for Morbid Obesity
Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke
Treatment of Dyslipidaemias - Related Resources